TERBINAFINE HYDROCHLORIDE

TERBINAFINE HYDROCHLORIDE was reported 8993 times

TERBINAFINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PYTHIUM INSIDIOSUM INFECTION 6 0.6000
1 ABSCESS SWEAT GLAND 6 0.1333
2 SOMATIC DELUSION 26 0.1057
3 FLUOROSIS 8 0.0930
4 SCEDOSPORIUM INFECTION 62 0.0878
5 DIAPHRAGMATIC SPASM 12 0.0811
6 MYCOTIC ENDOPHTHALMITIS 15 0.0794
7 SEPTAL PANNICULITIS 6 0.0750
8 TRICHOPHYTOSIS 15 0.0708
9 CHROMOBLASTOMYCOSIS 6 0.0706
10 TINEA CAPITIS 7 0.0609
11 RASH PAPULOSQUAMOUS 7 0.0464
12 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 78 0.0438
13 INTRAOCULAR PRESSURE TEST 10 0.0417
14 ERYTHEMA ANNULARE 12 0.0414
15 GENERALISED PUSTULAR PSORIASIS 11 0.0379
16 RESPIRATORY GAS EXCHANGE DISORDER 14 0.0377
17 ABSCESS FUNGAL 6 0.0343
18 DERMATOPHYTOSIS 9 0.0317
19 FUSARIUM INFECTION 21 0.0300
20 NAIL HYPERTROPHY 6 0.0296
21 BODY TINEA 16 0.0286
22 TRANSIENT ACANTHOLYTIC DERMATOSIS 8 0.0272
23 FAECAL VOLUME DECREASED 13 0.0271
24 VANCOMYCIN INFUSION REACTION 10 0.0265
25 URTICARIAL VASCULITIS 14 0.0265
26 EYE INFECTION FUNGAL 10 0.0258
27 PERIOSTITIS 11 0.0255
28 PROSTATIC HAEMORRHAGE 8 0.0251
29 TINEA VERSICOLOUR 9 0.0250
30 NAIL DYSTROPHY 13 0.0232
31 ONYCHOMYCOSIS 96 0.0219
32 DERMOID CYST 7 0.0210
33 FUNGAL FOOT INFECTION 9 0.0205
34 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 157 0.0202
35 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 16 0.0195
36 PITYRIASIS ROSEA 7 0.0188
37 INTERTRIGO 10 0.0183
38 PATHOGEN RESISTANCE 165 0.0181
39 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 15 0.0178
40 CHOLURIA 6 0.0176
41 CUTANEOUS LUPUS ERYTHEMATOSUS 34 0.0175
42 TINEA INFECTION 19 0.0172
43 GENE MUTATION IDENTIFICATION TEST POSITIVE 7 0.0166
44 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 13 0.0163
45 TINEA PEDIS 25 0.0157
46 CHRONIC SPONTANEOUS URTICARIA 18 0.0155
47 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 9 0.0155
48 OESOPHAGEAL IRRITATION 9 0.0155
49 NAIL PITTING 6 0.0152
50 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 16 0.0151
51 CHLOASMA 7 0.0151
52 DISSEMINATED ASPERGILLOSIS 7 0.0148
53 IMPETIGO 22 0.0148
54 PHAEOHYPHOMYCOSIS 7 0.0146
55 POLYSEROSITIS 6 0.0141
56 GLIOSIS 6 0.0140
57 SYSTEMIC MYCOSIS 16 0.0137
58 AGEUSIA 325 0.0130
59 PUSTULAR PSORIASIS 44 0.0128
60 FUNGAEMIA 20 0.0127
61 CARDIAC VALVE VEGETATION 6 0.0123
62 PUSTULE 29 0.0122
63 FAECES PALE 27 0.0121
64 CEREBRAL ASPERGILLOSIS 7 0.0114
65 OVARIAN FAILURE 6 0.0112
66 MUCOSAL EROSION 10 0.0110
67 CHOLESTATIC LIVER INJURY 24 0.0108
68 PSEUDOMONAL BACTERAEMIA 9 0.0105
69 SEBORRHOEIC DERMATITIS 17 0.0103
70 FUNGAL SKIN INFECTION 40 0.0099
71 XEROSIS 12 0.0097
72 HYPERPARATHYROIDISM SECONDARY 24 0.0096
73 RASH PUSTULAR 63 0.0086
74 NEPHROGENIC ANAEMIA 40 0.0086
75 ERYTHRODERMIC PSORIASIS 7 0.0085
76 DRUG RESISTANCE 210 0.0082
77 NEUROPSYCHIATRIC SYMPTOMS 7 0.0078
78 NAIL INFECTION 11 0.0077
79 PREMATURE MENOPAUSE 7 0.0076
80 BONE DEMINERALISATION 8 0.0076
81 ONYCHALGIA 7 0.0070
82 POUCHITIS 6 0.0070
83 REBOUND ACID HYPERSECRETION 21 0.0069
84 ANOGENITAL WARTS 6 0.0067
85 SALIVA ALTERED 6 0.0067
86 TEMPORAL ARTERITIS 6 0.0065
87 SOMATIC SYMPTOM DISORDER 7 0.0065
88 ERYTHEMA NODOSUM 22 0.0063
89 MACULE 17 0.0061
90 SKIN OEDEMA 6 0.0060
91 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
92 LIP DISCOLOURATION 7 0.0055
93 PRODUCT SELECTION ERROR 6 0.0055
94 LINEAR IGA DISEASE 9 0.0054
95 ADENOCARCINOMA GASTRIC 5 0.0054
96 HEPATITIS TOXIC 14 0.0054
97 ONYCHOLYSIS 8 0.0051
98 GASTROINTESTINAL MOTILITY DISORDER 27 0.0050
99 ERYTHEMA MULTIFORME 47 0.0050
100 PROTHROMBIN TIME SHORTENED 7 0.0050
101 SKIN PLAQUE 42 0.0050
102 NEUTROPHILIA 28 0.0049
103 NAIL DISCOLOURATION 19 0.0048
104 LATENT TUBERCULOSIS 10 0.0048
105 NORMOCYTIC ANAEMIA 7 0.0048
106 BILIARY OBSTRUCTION 6 0.0046
107 APLASTIC ANAEMIA 24 0.0046
108 HYPERSENSITIVITY VASCULITIS 12 0.0046
109 PAPULE 31 0.0044
110 ANTIPHOSPHOLIPID SYNDROME 7 0.0044
111 ANTINUCLEAR ANTIBODY POSITIVE 14 0.0043
112 AORTIC STENOSIS 15 0.0043
113 ANAL HAEMORRHAGE 12 0.0043
114 THROMBOTIC THROMBOCYTOPENIC PURPURA 15 0.0043
115 ABNORMAL LOSS OF WEIGHT 29 0.0042
116 URINE ODOUR ABNORMAL 25 0.0042
117 CONTRAINDICATED PRODUCT PRESCRIBED 7 0.0042
118 SEBORRHOEIC KERATOSIS 6 0.0041
119 DERMATITIS EXFOLIATIVE 20 0.0040
120 BRAIN ABSCESS 10 0.0039
121 DERMATITIS PSORIASIFORM 8 0.0039
122 VENOUS THROMBOSIS LIMB 8 0.0039
123 TOXIC SKIN ERUPTION 38 0.0038
124 PHOTOSENSITIVITY REACTION 62 0.0038
125 DERMATITIS BULLOUS 27 0.0037
126 DRUG-INDUCED LIVER INJURY 117 0.0037
127 INFUSION SITE BRUISING 8 0.0037
128 BILE DUCT OBSTRUCTION 7 0.0037
129 CUTANEOUS VASCULITIS 13 0.0036
130 FOOD AVERSION 6 0.0035
131 LUPUS-LIKE SYNDROME 32 0.0035
132 PERIORBITAL OEDEMA 18 0.0035
133 HAEMANGIOMA 8 0.0035
134 EXFOLIATIVE RASH 9 0.0034
135 PRURITUS GENITAL 8 0.0034
136 ABNORMAL FAECES 27 0.0033
137 HENOCH-SCHONLEIN PURPURA 7 0.0032
138 ASPERGILLUS INFECTION 21 0.0032
139 CHROMATURIA 72 0.0032
140 THROMBOPHLEBITIS 11 0.0031
141 END STAGE RENAL DISEASE 57 0.0031
142 HEPATOSPLENOMEGALY 8 0.0031
143 JAUNDICE CHOLESTATIC 11 0.0031
144 HYPERKERATOSIS 17 0.0031
145 CHRONIC KIDNEY DISEASE 234 0.0031
146 ABDOMINAL WALL HAEMATOMA 6 0.0031
147 SWELLING OF EYELID 19 0.0030
148 HEPATIC LESION 13 0.0030
149 ROSACEA 14 0.0030
150 HEPATITIS CHOLESTATIC 18 0.0030
151 LIP SWELLING 99 0.0030
152 DYSGEUSIA 220 0.0030
153 TONGUE ULCERATION 10 0.0030
154 EYELID PAIN 6 0.0029
155 FUNGAL INFECTION 98 0.0029
156 ANOSMIA 42 0.0029
157 JAUNDICE 77 0.0029
158 ENDOPHTHALMITIS 17 0.0028
159 FORCED EXPIRATORY VOLUME DECREASED 8 0.0028
160 ANHEDONIA 74 0.0028
161 CHOLESTASIS 54 0.0028
162 SKIN EROSION 9 0.0028
163 LIVER FUNCTION TEST ABNORMAL 81 0.0028
164 SKIN LESION 76 0.0028
165 RENAL TUBULAR ACIDOSIS 6 0.0027
166 MUCORMYCOSIS 7 0.0027
167 CONGESTIVE CARDIOMYOPATHY 11 0.0026
168 DERMATITIS CONTACT 30 0.0026
169 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 23 0.0026
170 DEPRESSION SUICIDAL 9 0.0026
171 TONGUE DISCOMFORT 11 0.0026
172 GAMBLING DISORDER 7 0.0026
173 ORAL DISCOMFORT 36 0.0026
174 LICHEN PLANUS 6 0.0026
175 SKIN WARM 15 0.0026
176 LIP BLISTER 7 0.0026
177 DRUG LEVEL BELOW THERAPEUTIC 14 0.0025
178 SUBCUTANEOUS ABSCESS 12 0.0025
179 LYMPHADENITIS 6 0.0025
180 BREATH ODOUR 6 0.0025
181 ALCOHOL USE 9 0.0024
182 RASH MACULO-PAPULAR 54 0.0024
183 ANAL PRURITUS 5 0.0024
184 JAW DISORDER 13 0.0024
185 ASTHENOPIA 13 0.0024
186 PURULENT DISCHARGE 10 0.0023
187 WOUND COMPLICATION 8 0.0023
188 RASH ERYTHEMATOUS 111 0.0023
189 CARDIAC TAMPONADE 11 0.0023
190 ACTINIC KERATOSIS 6 0.0023
191 ECONOMIC PROBLEM 35 0.0023
192 DERMATITIS 48 0.0023
193 SINUS BRADYCARDIA 22 0.0023
194 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
195 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
196 MOUTH SWELLING 13 0.0023
197 CHEILITIS 12 0.0022
198 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
199 PRODUCT ADMINISTRATION INTERRUPTED 17 0.0022
200 SQUAMOUS CELL CARCINOMA OF SKIN 13 0.0022
201 LUNG CONSOLIDATION 6 0.0021
202 DEAFNESS NEUROSENSORY 7 0.0021
203 CANDIDA INFECTION 35 0.0021
204 COMA SCALE ABNORMAL 6 0.0021
205 STEVENS-JOHNSON SYNDROME 46 0.0021
206 HEPATIC FIBROSIS 7 0.0020
207 GINGIVITIS 11 0.0020
208 RENAL TUBULAR NECROSIS 20 0.0020
209 PNEUMONIA FUNGAL 8 0.0020
210 TREATMENT FAILURE 168 0.0020
211 SKIN EXFOLIATION 169 0.0020
212 MIXED LIVER INJURY 6 0.0020
213 SKIN HYPERPIGMENTATION 17 0.0020
214 EMBOLISM VENOUS 6 0.0020
215 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
216 DRUG ERUPTION 35 0.0020
217 PNEUMONIA BACTERIAL 18 0.0020
218 MASTICATION DISORDER 6 0.0020
219 POLYURIA 16 0.0020
220 PHARYNGEAL SWELLING 19 0.0019
221 CHOLECYSTITIS ACUTE 11 0.0019
222 ATRIAL SEPTAL DEFECT 16 0.0019
223 PSYCHIATRIC SYMPTOM 14 0.0019
224 RASH GENERALISED 49 0.0019
225 GINGIVAL PAIN 15 0.0019
226 TASTE DISORDER 38 0.0019
227 STUPOR 6 0.0019
228 OSTEOPENIA 28 0.0018
229 SKIN SWELLING 16 0.0018
230 HEPATOCELLULAR INJURY 26 0.0018
231 DERMATITIS ALLERGIC 23 0.0018
232 MELANOCYTIC NAEVUS 8 0.0018
233 RASH MACULAR 63 0.0018
234 SALIVARY HYPERSECRETION 18 0.0018
235 EPIGASTRIC DISCOMFORT 7 0.0018
236 B-CELL LYMPHOMA 6 0.0018
237 MICTURITION URGENCY 20 0.0017
238 CANDIDIASIS 7 0.0017
239 VITAMIN D DEFICIENCY 17 0.0017
240 PAROSMIA 13 0.0017
241 GOITRE 7 0.0017
242 SKIN INFECTION 19 0.0017
243 SPUTUM DISCOLOURED 16 0.0017
244 ACUTE HEPATIC FAILURE 23 0.0017
245 ANAL ABSCESS 9 0.0017
246 DRUG INTERACTION 263 0.0017
247 QUALITY OF LIFE DECREASED 22 0.0016
248 FOOD INTOLERANCE 6 0.0016
249 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 42 0.0016
250 PARADOXICAL DRUG REACTION 6 0.0016
251 LIVER INJURY 40 0.0016
252 MUSCULOSKELETAL DISCOMFORT 28 0.0016
253 EAR INFECTION 43 0.0016
254 HEART RATE ABNORMAL 9 0.0016
255 AUTOIMMUNE HEPATITIS 11 0.0016
256 FORMICATION 11 0.0016
257 SWOLLEN TONGUE 49 0.0016
258 RENAL INJURY 46 0.0015
259 ACUTE KIDNEY INJURY 236 0.0015
260 HEPATOMEGALY 15 0.0015
261 MOUTH ULCERATION 32 0.0015
262 OESOPHAGEAL PAIN 6 0.0015
263 BLISTER 85 0.0015
264 ISCHAEMIC STROKE 27 0.0015
265 AGRANULOCYTOSIS 28 0.0015
266 MAJOR DEPRESSION 11 0.0015
267 NEPHROPATHY 14 0.0015
268 BRUXISM 8 0.0015
269 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 8 0.0015
270 ECCHYMOSIS 10 0.0015
271 TENDON RUPTURE 18 0.0015
272 SPINAL COMPRESSION FRACTURE 12 0.0014
273 HYPERTRANSAMINASAEMIA 10 0.0014
274 ONYCHOMADESIS 6 0.0014
275 PANCREATITIS ACUTE 32 0.0014
276 HYPERVOLAEMIA 7 0.0014
277 FOREIGN BODY SENSATION IN EYES 9 0.0014
278 ABSCESS LIMB 6 0.0014
279 SCAB 16 0.0014
280 GRAFT VERSUS HOST DISEASE 10 0.0014
281 HEPATITIS ACUTE 9 0.0014
282 OCULAR ICTERUS 6 0.0014
283 LEUKOCYTOSIS 25 0.0014
284 ATRIAL FLUTTER 11 0.0014
285 DIVERTICULUM INTESTINAL 6 0.0014
286 OBSESSIVE-COMPULSIVE DISORDER 11 0.0014
287 ORAL CANDIDIASIS 18 0.0014
288 RHABDOMYOLYSIS 57 0.0014
289 RENAL FAILURE 180 0.0014
290 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
291 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
292 HEPATIC CYTOLYSIS 17 0.0013
293 SERUM FERRITIN INCREASED 7 0.0013
294 RASH PRURITIC 71 0.0013
295 ORAL PAIN 29 0.0013
296 RED BLOOD CELL COUNT DECREASED 37 0.0013
297 APHTHOUS ULCER 10 0.0013
298 NORMAL NEWBORN 7 0.0013
299 RENAL IMPAIRMENT 108 0.0013
300 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
301 HYPOAESTHESIA ORAL 19 0.0013
302 RASH PAPULAR 28 0.0012
303 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
304 BONE DENSITY DECREASED 39 0.0012
305 URTICARIA 208 0.0012
306 COLECTOMY 7 0.0012
307 ANGINA UNSTABLE 8 0.0012
308 HYPOPHOSPHATAEMIA 9 0.0012
309 DEPRESSED MOOD 64 0.0012
310 INFLAMMATORY MARKER INCREASED 6 0.0012
311 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
312 ABDOMINAL TENDERNESS 6 0.0012
313 ERECTILE DYSFUNCTION 31 0.0012
314 DECREASED ACTIVITY 13 0.0012
315 ALTERED STATE OF CONSCIOUSNESS 26 0.0012
316 HYPERAMMONAEMIA 6 0.0012
317 EOSINOPHILIA 21 0.0012
318 SKIN MASS 8 0.0012
319 MENINGITIS 8 0.0012
320 CHOLECYSTITIS CHRONIC 8 0.0012
321 LYMPHADENOPATHY 42 0.0012
322 FACE OEDEMA 20 0.0012
323 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
324 HEARING IMPAIRED 7 0.0012
325 ONYCHOCLASIS 8 0.0012
326 HYPOCALCAEMIA 22 0.0012
327 SKIN NECROSIS 6 0.0012
328 RASH 503 0.0012
329 PETECHIAE 12 0.0011
330 DEVICE OCCLUSION 16 0.0011
331 OVERWEIGHT 6 0.0011
332 VASCULITIS 13 0.0011
333 STRESS FRACTURE 6 0.0011
334 ECZEMA 58 0.0011
335 SKIN LACERATION 12 0.0011
336 PRURITUS 424 0.0011
337 PSORIASIS 144 0.0011
338 IMPAIRED GASTRIC EMPTYING 15 0.0011
339 HEPATIC ENZYME INCREASED 75 0.0011
340 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
341 MANIA 18 0.0011
342 SWELLING FACE 71 0.0011
343 THERAPY PARTIAL RESPONDER 17 0.0011
344 BODY TEMPERATURE INCREASED 22 0.0011
345 STREPTOCOCCAL INFECTION 6 0.0011
346 HEPATOTOXICITY 24 0.0011
347 INTRACRANIAL PRESSURE INCREASED 6 0.0011
348 SKIN FISSURES 21 0.0011
349 HEMIPARESIS 18 0.0011
350 PEMPHIGOID 8 0.0011
351 PERIPHERAL SWELLING 163 0.0011
352 PARANOIA 18 0.0010
353 INCONTINENCE 11 0.0010
354 RESTLESSNESS 38 0.0010
355 FOOD ALLERGY 8 0.0010
356 DISCOMFORT 63 0.0010
357 DEAFNESS 27 0.0010
358 EYELID OEDEMA 12 0.0010
359 LOCAL SWELLING 18 0.0010
360 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
361 NAIL DISORDER 9 0.0010
362 HAEMORRHOIDS 20 0.0010
363 BLOOD TESTOSTERONE DECREASED 7 0.0010
364 TINNITUS 47 0.0010
365 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 56 0.0010
366 URINARY RETENTION 34 0.0010
367 BRADYKINESIA 6 0.0010
368 BODY TEMPERATURE DECREASED 10 0.0010
369 DROOLING 7 0.0010
370 LARGE INTESTINE POLYP 7 0.0010
371 GASTROINTESTINAL INFECTION 9 0.0010
372 PAIN OF SKIN 27 0.0010
373 WOUND 28 0.0010
374 BONE LOSS 15 0.0010
375 DENTAL CARIES 11 0.0010
376 SENSORY LOSS 8 0.0010
377 CELLULITIS 50 0.0010
378 THERMAL BURN 7 0.0010
379 TENSION 6 0.0010
380 TOOTH ABSCESS 10 0.0010
381 HEPATITIS 25 0.0010
382 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
383 DRUG ABUSER 6 0.0010
384 DEPRESSION 221 0.0010
385 ANAPHYLACTIC SHOCK 25 0.0010
386 PHARYNGITIS 12 0.0010
387 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
388 HYPERBILIRUBINAEMIA 10 0.0010
389 TOOTH LOSS 20 0.0010
390 HEPATIC FUNCTION ABNORMAL 36 0.0010
391 PRE-EXISTING CONDITION IMPROVED 6 0.0010
392 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
393 BRAIN FOG 15 0.0010
394 PHOTOPHOBIA 18 0.0010
395 AKATHISIA 13 0.0010
396 ANGIOEDEMA 42 0.0009
397 OSTEOPOROSIS 39 0.0009
398 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
399 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 16 0.0009
400 BURNING SENSATION 66 0.0009
401 LETHARGY 54 0.0009
402 BODY HEIGHT DECREASED 10 0.0009
403 ERYTHEMA 192 0.0009
404 LIVER FUNCTION TEST INCREASED 20 0.0009
405 CARDIAC FLUTTER 6 0.0009
406 DIZZINESS POSTURAL 9 0.0009
407 ARTHRITIS 73 0.0009
408 PRODUCT USE IN UNAPPROVED INDICATION 230 0.0009
409 SKIN REACTION 13 0.0009
410 BIPOLAR DISORDER 10 0.0009
411 HYPERTHERMIA 7 0.0009
412 ANXIETY 260 0.0009
413 HYPOGAMMAGLOBULINAEMIA 6 0.0009
414 INFLAMMATION 47 0.0009
415 LIGAMENT SPRAIN 9 0.0009
416 ADRENAL INSUFFICIENCY 11 0.0009
417 NASAL CONGESTION 53 0.0009
418 SYSTEMIC LUPUS ERYTHEMATOSUS 32 0.0009
419 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
420 HYPOPHAGIA 23 0.0009
421 SKIN DISORDER 30 0.0009
422 FEELING COLD 25 0.0009
423 PANCYTOPENIA 50 0.0009
424 ILEUS 11 0.0009
425 DECREASED APPETITE 205 0.0009
426 HIDRADENITIS 8 0.0009
427 SKIN HAEMORRHAGE 13 0.0009
428 RESPIRATION ABNORMAL 6 0.0009
429 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
430 LOCALISED INFECTION 21 0.0009
431 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
432 PERSONALITY CHANGE 8 0.0009
433 APHASIA 26 0.0009
434 FOLLICULITIS 9 0.0009
435 BLOOD COUNT ABNORMAL 13 0.0009
436 C-REACTIVE PROTEIN INCREASED 31 0.0009
437 DRUG DISPENSING ERROR 13 0.0008
438 INSURANCE ISSUE 13 0.0008
439 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
440 DRUG LEVEL INCREASED 14 0.0008
441 BLOOD URINE PRESENT 16 0.0008
442 PRODUCT SUPPLY ISSUE 6 0.0008
443 NEUTROPENIC SEPSIS 6 0.0008
444 EOSINOPHIL COUNT INCREASED 7 0.0008
445 GOUT 15 0.0008
446 DISORIENTATION 33 0.0008
447 PARAESTHESIA ORAL 12 0.0008
448 PANIC REACTION 6 0.0008
449 CONDITION AGGRAVATED 252 0.0008
450 SEPTIC SHOCK 36 0.0008
451 PANIC ATTACK 30 0.0008
452 THERAPY NON-RESPONDER 37 0.0008
453 DISEASE RECURRENCE 39 0.0008
454 VITAMIN D DECREASED 7 0.0008
455 EMOTIONAL DISTRESS 99 0.0008
456 INFLAMMATORY BOWEL DISEASE 8 0.0008
457 PSEUDOMONAS INFECTION 7 0.0008
458 SCIATICA 13 0.0008
459 ANURIA 7 0.0008
460 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
461 ARTHROPOD BITE 6 0.0008
462 RESPIRATORY FAILURE 59 0.0008
463 LIMB DISCOMFORT 25 0.0008
464 EYE SWELLING 30 0.0008
465 HALLUCINATION, VISUAL 17 0.0008
466 SUNBURN 6 0.0008
467 WEIGHT DECREASED 224 0.0008
468 EYE INFECTION 9 0.0008
469 SPINAL OSTEOARTHRITIS 7 0.0008
470 IMPAIRED DRIVING ABILITY 9 0.0008
471 MULTIPLE FRACTURES 13 0.0008
472 PURPURA 7 0.0008
473 FEEDING DISORDER 16 0.0008
474 BONE MARROW FAILURE 16 0.0008
475 DRUG LEVEL DECREASED 8 0.0008
476 MYOCARDITIS 9 0.0008
477 BOWEL MOVEMENT IRREGULARITY 6 0.0008
478 ACUTE RESPIRATORY FAILURE 15 0.0008
479 LOSS OF LIBIDO 7 0.0008
480 RIB FRACTURE 16 0.0008
481 BLOOD BILIRUBIN INCREASED 21 0.0008
482 ENCEPHALOPATHY 19 0.0008
483 NEUTROPENIA 105 0.0008
484 VENTRICULAR EXTRASYSTOLES 8 0.0008
485 RESTLESS LEGS SYNDROME 14 0.0008
486 HAEMORRHAGIC STROKE 6 0.0008
487 TENDERNESS 8 0.0008
488 EXOSTOSIS 7 0.0008
489 PSORIATIC ARTHROPATHY 31 0.0008
490 DERMATITIS ATOPIC 40 0.0008
491 NASAL DISCOMFORT 6 0.0008
492 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
493 OEDEMA 41 0.0008
494 APPETITE DISORDER 5 0.0008
495 SUICIDAL IDEATION 69 0.0008
496 NIGHTMARE 26 0.0008
497 SENSORY DISTURBANCE 12 0.0007
498 MYALGIA 127 0.0007
499 PRODUCT SUBSTITUTION ISSUE 43 0.0007
500 HYPONATRAEMIA 42 0.0007
501 EYE PRURITUS 25 0.0007
502 SQUAMOUS CELL CARCINOMA 7 0.0007
503 FRACTURE 14 0.0007
504 DISEASE PROGRESSION 87 0.0007
505 HICCUPS 6 0.0007
506 HYPERAESTHESIA 6 0.0007
507 DRUG PRESCRIBING ERROR 14 0.0007
508 GASTROINTESTINAL PAIN 8 0.0007
509 GENERALISED OEDEMA 9 0.0007
510 TOOTH FRACTURE 8 0.0007
511 ABNORMAL DREAMS 20 0.0007
512 MUSCLE INJURY 6 0.0007
513 GASTRITIS 19 0.0007
514 FOOT DEFORMITY 8 0.0007
515 COAGULOPATHY 12 0.0007
516 EPILEPSY 22 0.0007
517 NEPHROLITHIASIS 33 0.0007
518 LIVE BIRTH 6 0.0007
519 ASCITES 21 0.0007
520 TACHYCARDIA 63 0.0007
521 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
522 JOINT INJURY 15 0.0007
523 OROPHARYNGEAL PAIN 65 0.0007
524 HAEMATURIA 24 0.0007
525 RECTAL HAEMORRHAGE 30 0.0007
526 PALLOR 19 0.0007
527 POOR QUALITY SLEEP 15 0.0007
528 MOOD ALTERED 19 0.0007
529 SKIN DISCOLOURATION 32 0.0007
530 HIATUS HERNIA 9 0.0007
531 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
532 PRURITUS GENERALISED 15 0.0007
533 DELIRIUM 24 0.0007
534 INFECTION 100 0.0007
535 DRY MOUTH 56 0.0007
536 HALLUCINATION 52 0.0007
537 FOOT FRACTURE 13 0.0007
538 EXTRAPYRAMIDAL DISORDER 17 0.0007
539 MEDICATION ERROR 38 0.0007
540 SPLENOMEGALY 8 0.0007
541 EAR DISCOMFORT 7 0.0007
542 ABDOMINAL DISTENSION 71 0.0007
543 DYSURIA 25 0.0007
544 LYMPHOCYTE COUNT DECREASED 12 0.0007
545 BLOOD POTASSIUM INCREASED 11 0.0007
546 MYOSITIS 6 0.0007
547 THERAPEUTIC RESPONSE UNEXPECTED 30 0.0007
548 MUSCULOSKELETAL PAIN 35 0.0007
549 DISTURBANCE IN ATTENTION 36 0.0007
550 OROPHARYNGEAL DISCOMFORT 6 0.0007
551 HYPERSOMNIA 19 0.0007
552 LIMB INJURY 18 0.0007
553 ABDOMINAL DISCOMFORT 111 0.0007
554 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
555 SCHIZOPHRENIA 8 0.0007
556 ATRIAL FIBRILLATION 64 0.0007
557 SINUS DISORDER 13 0.0007
558 BREAST PAIN 7 0.0007
559 ANKLE FRACTURE 10 0.0006
560 FAECES DISCOLOURED 14 0.0006
561 SEPSIS 72 0.0006
562 METRORRHAGIA 11 0.0006
563 APHONIA 9 0.0006
564 CEREBRAL HAEMORRHAGE 23 0.0006
565 VERTIGO 39 0.0006
566 PEMPHIGUS 8 0.0006
567 ARTERIOSCLEROSIS 6 0.0006
568 PARAESTHESIA 100 0.0006
569 ALOPECIA 124 0.0006
570 ABNORMAL BEHAVIOUR 25 0.0006
571 DRUG INEFFECTIVE 831 0.0006
572 TOOTH DISORDER 14 0.0006
573 FREQUENT BOWEL MOVEMENTS 17 0.0006
574 SLEEP APNOEA SYNDROME 12 0.0006
575 HYPERHIDROSIS 81 0.0006
576 ABSCESS 10 0.0006
577 GLOSSODYNIA 14 0.0006
578 SNEEZING 14 0.0006
579 HYPERCHOLESTEROLAEMIA 6 0.0006
580 NIGHT SWEATS 20 0.0006
581 STATUS EPILEPTICUS 7 0.0006
582 REBOUND EFFECT 7 0.0006
583 ALANINE AMINOTRANSFERASE INCREASED 38 0.0006
584 EAR PAIN 12 0.0006
585 BACK DISORDER 10 0.0006
586 ORAL HERPES 12 0.0006
587 CHOLELITHIASIS 20 0.0006
588 TOOTH INFECTION 8 0.0006
589 VENTRICULAR TACHYCARDIA 10 0.0006
590 HAEMATOCRIT DECREASED 12 0.0006
591 PULMONARY MASS 9 0.0006
592 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
593 BONE DISORDER 11 0.0006
594 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
595 SWELLING 56 0.0006
596 ABDOMINAL PAIN UPPER 123 0.0006
597 MALAISE 262 0.0006
598 CYSTITIS 19 0.0006
599 CONFUSIONAL STATE 96 0.0006
600 CONJUNCTIVITIS 11 0.0006
601 HYPERSENSITIVITY 110 0.0006
602 SINUS CONGESTION 8 0.0006
603 HEPATIC STEATOSIS 11 0.0006
604 CHOLECYSTITIS 7 0.0006
605 INITIAL INSOMNIA 6 0.0006
606 TRANSAMINASES INCREASED 13 0.0006
607 ABDOMINAL PAIN 136 0.0006
608 THERAPY CESSATION 30 0.0006
609 NEEDLE ISSUE 17 0.0006
610 DYSPHAGIA 55 0.0006
611 IMPAIRED HEALING 19 0.0006
612 BASAL CELL CARCINOMA 9 0.0006
613 NOCTURIA 7 0.0006
614 PAIN 354 0.0006
615 POLLAKIURIA 24 0.0006
616 HEART RATE INCREASED 57 0.0006
617 HYPOMAGNESAEMIA 8 0.0006
618 RHINORRHOEA 37 0.0006
619 CYANOSIS 9 0.0006
620 MUSCULAR WEAKNESS 65 0.0006
621 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
622 SCRATCH 6 0.0006
623 ARTHRALGIA 236 0.0006
624 FULL BLOOD COUNT ABNORMAL 6 0.0006
625 SLEEP DISORDER 40 0.0006
626 BLOOD CREATININE INCREASED 37 0.0006
627 PYREXIA 196 0.0006
628 CYST 7 0.0006
629 LIVER DISORDER 25 0.0006
630 INSOMNIA 150 0.0006
631 DRY SKIN 75 0.0006
632 CHEST PAIN 104 0.0006
633 INTENTIONAL DOSE OMISSION 16 0.0006
634 PNEUMONIA ASPIRATION 14 0.0006
635 GALLBLADDER DISORDER 10 0.0006
636 AGGRESSION 28 0.0006
637 DYSARTHRIA 21 0.0006
638 IMPAIRED QUALITY OF LIFE 8 0.0006
639 MUSCLE TIGHTNESS 9 0.0006
640 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
641 GASTROENTERITIS VIRAL 10 0.0006
642 VISION BLURRED 76 0.0006
643 GENERAL PHYSICAL HEALTH DETERIORATION 64 0.0006
644 MUSCLE ATROPHY 7 0.0006
645 MUSCULOSKELETAL STIFFNESS 48 0.0005
646 ASPIRATION 6 0.0005
647 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
648 PRODUCT PRESCRIBING ERROR 13 0.0005
649 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10 0.0005
650 ROTATOR CUFF SYNDROME 7 0.0005
651 HAEMATOCHEZIA 30 0.0005
652 PLEURAL EFFUSION 33 0.0005
653 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
654 NEUTROPHIL COUNT DECREASED 22 0.0005
655 EYE IRRITATION 31 0.0005
656 GASTROINTESTINAL HAEMORRHAGE 45 0.0005
657 FEELING HOT 33 0.0005
658 CHILLS 63 0.0005
659 THROMBOCYTOPENIA 60 0.0005
660 OCULAR DISCOMFORT 6 0.0005
661 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
662 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
663 IMMUNE SYSTEM DISORDER 7 0.0005
664 ABORTION INDUCED 5 0.0005
665 PANCREATITIS 28 0.0005
666 DYSPEPSIA 52 0.0005
667 CIRCULATORY COLLAPSE 9 0.0005
668 WHITE BLOOD CELL COUNT DECREASED 57 0.0005
669 MUSCULOSKELETAL DISORDER 10 0.0005
670 OEDEMA PERIPHERAL 64 0.0005
671 SHOCK 12 0.0005
672 DRY EYE 26 0.0005
673 COUGH 146 0.0005
674 FATIGUE 405 0.0005
675 PHARYNGEAL OEDEMA 8 0.0005
676 LEUKOPENIA 26 0.0005
677 CONTUSION 50 0.0005
678 OSTEOARTHRITIS 22 0.0005
679 NECK PAIN 29 0.0005
680 PAIN IN EXTREMITY 152 0.0005
681 SPEECH DISORDER 27 0.0005
682 NEUROPATHY PERIPHERAL 49 0.0005
683 RENAL DISORDER 24 0.0005
684 BLOOD CHOLESTEROL INCREASED 24 0.0005
685 EYE PAIN 29 0.0005
686 DYSSTASIA 15 0.0005
687 ACUTE MYELOID LEUKAEMIA 8 0.0005
688 HYPERKALAEMIA 18 0.0005
689 FEBRILE NEUTROPENIA 34 0.0005
690 FLUSHING 52 0.0005
691 THERAPEUTIC RESPONSE DECREASED 31 0.0005
692 VAGINAL HAEMORRHAGE 22 0.0005
693 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
694 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
695 HERPES ZOSTER 29 0.0005
696 PROCEDURAL PAIN 14 0.0005
697 BLOOD PRESSURE ABNORMAL 10 0.0005
698 OBESITY 8 0.0005
699 HYPERLIPIDAEMIA 6 0.0005
700 DEMENTIA 14 0.0005
701 DIPLOPIA 13 0.0005
702 CARPAL TUNNEL SYNDROME 7 0.0005
703 DIABETIC KETOACIDOSIS 12 0.0005
704 HEPATIC FAILURE 15 0.0005
705 TOOTHACHE 9 0.0005
706 BLOOD PRESSURE INCREASED 76 0.0005
707 JOINT SWELLING 60 0.0005
708 LACRIMATION INCREASED 15 0.0005
709 MULTIPLE SCLEROSIS RELAPSE 34 0.0005
710 DIZZINESS 247 0.0005
711 LYMPHOPENIA 7 0.0005
712 SEASONAL ALLERGY 7 0.0005
713 BURSITIS 6 0.0005
714 INFLUENZA 55 0.0005
715 SINUS TACHYCARDIA 7 0.0005
716 URINARY TRACT INFECTION 84 0.0005
717 DEEP VEIN THROMBOSIS 32 0.0005
718 NAUSEA 389 0.0005
719 HEADACHE 308 0.0005
720 GAIT DISTURBANCE 94 0.0005
721 RESPIRATORY DEPRESSION 6 0.0005
722 PARALYSIS 7 0.0005
723 SINUSITIS 50 0.0005
724 HEART RATE IRREGULAR 11 0.0005
725 EYE DISORDER 16 0.0005
726 ABNORMAL WEIGHT GAIN 6 0.0005
727 APPLICATION SITE PRURITUS 11 0.0005
728 FEAR 13 0.0005
729 PERITONITIS 10 0.0005
730 BACTERIAL INFECTION 9 0.0005
731 TOOTH EXTRACTION 6 0.0005
732 THROAT TIGHTNESS 13 0.0005
733 HEPATIC CIRRHOSIS 9 0.0005
734 ASTHMA 54 0.0005
735 BLOOD SODIUM DECREASED 9 0.0005
736 HYPOKALAEMIA 22 0.0005
737 MUSCLE SPASMS 87 0.0005
738 HAEMATEMESIS 12 0.0005
739 MOBILITY DECREASED 34 0.0005
740 WHEEZING 28 0.0005
741 DYSPNOEA 267 0.0005
742 BACK PAIN 109 0.0005
743 IMPAIRED WORK ABILITY 10 0.0005
744 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
745 ANOREXIA 6 0.0005
746 SKIN ULCER 12 0.0005
747 ASTHENIA 174 0.0005
748 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
749 DIARRHOEA 298 0.0005
750 NASOPHARYNGITIS 85 0.0005
751 BONE PAIN 27 0.0005
752 ORTHOSTATIC HYPOTENSION 8 0.0005
753 PRODUCT PRESCRIBING ISSUE 10 0.0005
754 KIDNEY INFECTION 9 0.0005
755 INJURY 32 0.0005
756 PULMONARY CONGESTION 6 0.0005
757 DEVICE RELATED INFECTION 7 0.0005
758 APPLICATION SITE PAIN 10 0.0005
759 PALPITATIONS 53 0.0005
760 NEURALGIA 11 0.0005
761 DYSPNOEA EXERTIONAL 17 0.0005
762 BALANCE DISORDER 39 0.0005
763 DELUSION 7 0.0005
764 COLITIS 17 0.0004
765 RENAL FAILURE ACUTE 19 0.0004
766 HYPOAESTHESIA 67 0.0004
767 GASTROINTESTINAL DISORDER 40 0.0004
768 INTENTIONAL SELF-INJURY 9 0.0004
769 STOMATITIS 27 0.0004
770 PRODUCT TASTE ABNORMAL 6 0.0004
771 PNEUMOTHORAX 7 0.0004
772 PSYCHOTIC DISORDER 13 0.0004
773 ULCER 7 0.0004
774 PRODUCTIVE COUGH 21 0.0004
775 APPLICATION SITE RASH 6 0.0004
776 MOVEMENT DISORDER 14 0.0004
777 VISUAL IMPAIRMENT 54 0.0004
778 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
779 DIVERTICULITIS 12 0.0004
780 LACTIC ACIDOSIS 14 0.0004
781 CONSTIPATION 94 0.0004
782 HUNGER 6 0.0004
783 COORDINATION ABNORMAL 6 0.0004
784 LOSS OF CONSCIOUSNESS 55 0.0004
785 COGNITIVE DISORDER 20 0.0004
786 COVID-19 75 0.0004
787 PNEUMONIA 138 0.0004
788 OSTEONECROSIS 14 0.0004
789 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
790 HYPOXIA 15 0.0004
791 PRODUCT USE ISSUE 80 0.0004
792 STAPHYLOCOCCAL INFECTION 14 0.0004
793 DRUG ADMINISTRATION ERROR 13 0.0004
794 RESPIRATORY TRACT INFECTION 11 0.0004
795 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
796 MUCOSAL INFLAMMATION 11 0.0004
797 SEDATION 11 0.0004
798 CATARACT 25 0.0004
799 FEELING JITTERY 8 0.0004
800 SKIN BURNING SENSATION 30 0.0004
801 BLOOD UREA INCREASED 7 0.0004
802 SKIN CANCER 9 0.0004
803 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
804 HYPOKINESIA 6 0.0004
805 DRUG EFFECT INCOMPLETE 15 0.0004
806 CRYING 15 0.0004
807 FALL 137 0.0004
808 APATHY 6 0.0004
809 HOT FLUSH 31 0.0004
810 HEAD INJURY 13 0.0004
811 CHEST DISCOMFORT 42 0.0004
812 SYNCOPE 41 0.0004
813 AGITATION 30 0.0004
814 MOOD SWINGS 13 0.0004
815 ACUTE MYOCARDIAL INFARCTION 12 0.0004
816 LABORATORY TEST ABNORMAL 12 0.0004
817 OFF LABEL USE 354 0.0004
818 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
819 TREATMENT NONCOMPLIANCE 22 0.0004
820 AMENORRHOEA 7 0.0004
821 MIGRAINE 38 0.0004
822 ILLNESS 41 0.0004
823 FULL BLOOD COUNT DECREASED 8 0.0004
824 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
825 THERAPY INTERRUPTED 28 0.0004
826 BRONCHITIS 29 0.0004
827 GAIT INABILITY 13 0.0004
828 INFLUENZA LIKE ILLNESS 32 0.0004
829 MUSCULOSKELETAL CHEST PAIN 6 0.0004
830 HYPERTENSION 82 0.0004
831 ANGER 13 0.0004
832 ACNE 29 0.0004
833 ANAPHYLACTIC REACTION 21 0.0004
834 OCULAR HYPERAEMIA 18 0.0004
835 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
836 THROAT IRRITATION 17 0.0004
837 ARTHROPATHY 21 0.0004
838 RESPIRATORY TRACT CONGESTION 6 0.0004
839 RETCHING 8 0.0004
840 BLOOD PRESSURE FLUCTUATION 9 0.0004
841 HYPOACUSIS 16 0.0004
842 RESPIRATORY DISORDER 11 0.0004
843 ADVERSE DRUG REACTION 33 0.0004
844 WEIGHT INCREASED 82 0.0004
845 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
846 POST PROCEDURAL COMPLICATION 7 0.0004
847 HERNIA 7 0.0004
848 ERUCTATION 7 0.0004
849 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
850 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
851 CYTOMEGALOVIRUS INFECTION 6 0.0004
852 DEHYDRATION 48 0.0004
853 CHOKING 7 0.0004
854 SURGERY 21 0.0004
855 CARDIOVASCULAR DISORDER 9 0.0004
856 DIABETES MELLITUS 27 0.0004
857 FLATULENCE 20 0.0004
858 SCAR 6 0.0004
859 PRODUCT DOSE OMISSION ISSUE 103 0.0003
860 SPINAL FRACTURE 7 0.0003
861 INTESTINAL OBSTRUCTION 13 0.0003
862 APPLICATION SITE ERYTHEMA 9 0.0003
863 VOMITING 161 0.0003
864 MEMORY IMPAIRMENT 47 0.0003
865 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
866 OXYGEN SATURATION DECREASED 19 0.0003
867 FEELING ABNORMAL 81 0.0003
868 ARRHYTHMIA 16 0.0003
869 PULMONARY HYPERTENSION 7 0.0003
870 THIRST 6 0.0003
871 MULTIPLE SCLEROSIS 16 0.0003
872 EPISTAXIS 25 0.0003
873 TREMOR 55 0.0003
874 OSTEOMYELITIS 6 0.0003
875 INTENTIONAL PRODUCT MISUSE 29 0.0003
876 EXPIRED PRODUCT ADMINISTERED 11 0.0003
877 CORONARY ARTERY DISEASE 10 0.0003
878 HYPOGLYCAEMIA 16 0.0003
879 FIBROMYALGIA 8 0.0003
880 EATING DISORDER 7 0.0003
881 CEREBRAL INFARCTION 8 0.0003
882 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 59 0.0003
883 RHEUMATOID ARTHRITIS 37 0.0003
884 MENTAL STATUS CHANGES 9 0.0003
885 PRODUCT DOSE OMISSION 21 0.0003
886 EXTRA DOSE ADMINISTERED 13 0.0003
887 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
888 BLOOD PRESSURE DECREASED 21 0.0003
889 IRRITABILITY 19 0.0003
890 PROTEINURIA 6 0.0003
891 COLITIS ULCERATIVE 14 0.0003
892 METABOLIC ACIDOSIS 10 0.0003
893 SEIZURE 36 0.0003
894 HIP FRACTURE 10 0.0003
895 THROMBOSIS 25 0.0003
896 SOMNOLENCE 62 0.0003
897 DYSPHONIA 18 0.0003
898 AMNESIA 20 0.0003
899 INJECTION SITE REACTION 21 0.0003
900 URINARY INCONTINENCE 9 0.0003
901 PERICARDIAL EFFUSION 7 0.0003
902 VISUAL ACUITY REDUCED 10 0.0003
903 DRUG INTOLERANCE 29 0.0003
904 MENTAL DISORDER 13 0.0003
905 HAEMORRHAGE 31 0.0003
906 HAEMOGLOBIN DECREASED 30 0.0003
907 RESPIRATORY DISTRESS 8 0.0003
908 MENTAL IMPAIRMENT 7 0.0003
909 NERVOUSNESS 15 0.0003
910 CARDIAC FAILURE CONGESTIVE 23 0.0003
911 PAIN IN JAW 8 0.0003
912 HYPOTHYROIDISM 9 0.0003
913 ANGINA PECTORIS 8 0.0003
914 CARDIAC ARREST 23 0.0003
915 UNEVALUABLE EVENT 21 0.0003
916 PRODUCT DISPENSING ERROR 6 0.0003
917 ANAEMIA 52 0.0003
918 UNRESPONSIVE TO STIMULI 7 0.0003
919 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
920 JOINT STIFFNESS 7 0.0003
921 BLOOD POTASSIUM DECREASED 8 0.0003
922 CONVULSION 15 0.0003
923 GASTRIC DISORDER 9 0.0003
924 SKIN IRRITATION 12 0.0003
925 MENSTRUATION IRREGULAR 7 0.0003
926 EMOTIONAL DISORDER 8 0.0003
927 HEART RATE DECREASED 9 0.0003
928 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
929 PULMONARY EMBOLISM 24 0.0003
930 TARDIVE DYSKINESIA 7 0.0002
931 ILL-DEFINED DISORDER 15 0.0002
932 PRESYNCOPE 6 0.0002
933 INJECTION SITE URTICARIA 6 0.0002
934 ABASIA 6 0.0002
935 INFUSION RELATED REACTION 16 0.0002
936 ROAD TRAFFIC ACCIDENT 10 0.0002
937 ADVERSE EVENT 22 0.0002
938 WITHDRAWAL SYNDROME 10 0.0002
939 TYPE 2 DIABETES MELLITUS 8 0.0002
940 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
941 FLUID RETENTION 12 0.0002
942 HAEMATOMA 6 0.0002
943 PLASMA CELL MYELOMA 9 0.0002
944 PLATELET COUNT DECREASED 23 0.0002
945 VIRAL INFECTION 7 0.0002
946 OVERDOSE 45 0.0002
947 CEREBROVASCULAR ACCIDENT 34 0.0002
948 ABDOMINAL PAIN LOWER 5 0.0002
949 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
950 TOXICITY TO VARIOUS AGENTS 32 0.0002
951 HYPOTENSION 38 0.0002
952 INJECTION SITE BRUISING 15 0.0002
953 DRUG EFFECT DECREASED 10 0.0002
954 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
955 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
956 PULMONARY OEDEMA 8 0.0002
957 MYOCARDIAL INFARCTION 31 0.0002
958 DRUG DOSE OMISSION 29 0.0002
959 CARDIAC DISORDER 16 0.0002
960 BRADYCARDIA 9 0.0002
961 HYPERGLYCAEMIA 6 0.0002
962 LUNG DISORDER 8 0.0002
963 INJECTION SITE MASS 6 0.0002
964 INCORRECT DOSE ADMINISTERED 37 0.0002
965 PROSTATE CANCER 13 0.0002
966 DEVICE LEAKAGE 7 0.0002
967 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
968 INJECTION SITE PAIN 47 0.0002
969 BLOOD GLUCOSE INCREASED 28 0.0001
970 BLINDNESS 6 0.0001
971 INJECTION SITE ERYTHEMA 18 0.0001
972 COMPLETED SUICIDE 12 0.0001
973 INTENTIONAL OVERDOSE 9 0.0001
974 PRODUCT QUALITY ISSUE 19 0.0001
975 CARDIAC FAILURE 11 0.0001
976 ACCIDENTAL OVERDOSE 5 0.0001
977 SUICIDE ATTEMPT 8 0.0001
978 INJECTION SITE SWELLING 10 0.0001
979 EXPOSURE DURING PREGNANCY 8 0.0001
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
981 HOSPITALISATION 19 0.0001
982 DEVICE ISSUE 11 0.0001
983 DEVICE MALFUNCTION 8 0.0001
984 DEATH 98 0.0001
985 UNDERDOSE 8 0.0001
986 INJECTION SITE PRURITUS 7 0.0001
987 INJECTION SITE HAEMORRHAGE 6 0.0001
988 DRUG DEPENDENCE 11 0.0001
989 NO ADVERSE EVENT 12 0.0001